Yun Wu

• State University of New York at Buffalo

  Professor

Sources: reporter.nih.gov

• National Cancer Institute

  R01, Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay, R01CA272827, 2022–2027, 10 Sept 2025

• National Cancer Institute

  R21, Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection, R21CA267934, 2022–2025, 3 Aug 2023

Sources: reporter.nih.gov